MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ard.2025.11.027

Медицинская библиотека · Annals of the rheumatic diseases · 2025

Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis.

Rosendahl Ann-Helen S, Bornikoel Anna, Zeinert Isabel, Keufgens Lena, Tellkamp Frederik, Kleinenkuhnen Niklas, Baar Till, Schönborn Katrin, Krüger Marcus, Tresch Achim, Brachvogel Bent, Eckes Beate, Moinzadeh Pia, Krieg Thomas

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Systemic sclerosis (SSc) is an autoimmune-driven fibrotic disease, characterised by excessive extracellular matrix (ECM) deposition and fibroblast activation. Our study aimed to identify novel fibroblast subpopulations in SSc and determine their functional role.

METHODS

We performed single-cell RNA sequencing on cultured dermal fibroblasts from healthy donors and patients with diffuse cutaneous SSc, verified selected, specific genes at the protein level and used siRNA knockdown experiments to provide evidence for a functional role of these proteins.

RESULTS

SSc fibroblasts revealed high heterogeneity and in specific activated subsets strong upregulation of CD9 and four and a half LIM domain 1 (FHL1), previously described as a muscle-related protein. Overexpression of FHL1 and CD9 was also detected in fibroblast subsets in patient skin. CD9 was associated with the regulation of FHL1 expression. Downmodulation of FHL1 in primary skin fibroblasts correlated with downregulation of the vestigial-like family member 3 (VGLL3) gene, which is known to be expressed in myofibroblasts in a stiff and fibrotic environment and to upregulate collagen synthesis. Further, VGLL3 was confirmed to be upregulated in SSc donor skin.

CONCLUSIONS

Our study identified novel fibroblast subsets in SSc, characterised by CD9 and/or FHL1 upregulation. The data indicate a functional role of FHL1 in fibroblasts and its involvement in the regulation of ECM production and provide a new mechanistic link to VGLL3 regulation. Our findings suggest new avenues for therapeutic exploration targeting the perpetuating fibroblast activation by the fibrotic environment.

Для цитирования: Rosendahl Ann-Helen S, Bornikoel Anna, Zeinert Isabel, Keufgens Lena, Tellkamp Frederik, Kleinenkuhnen Niklas, Baar Till, Schönborn Katrin, Krüger Marcus, Tresch Achim, Brachvogel Bent, Eckes Beate, Moinzadeh Pia, Krieg Thomas. Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis.. Annals of the rheumatic diseases. 2025. DOI: 10.1016/j.ard.2025.11.027.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.